KarMMa-RW: comparison of idecabtagene vicleucel with real-world outcomes in relapsed and refractory multiple myelomaSundar Jagannath, David S. Siegel, Hartmut Goldschmidt et al.|Blood Cancer Journal|2021Cited by 89